King's College Hospital, London, UK.
Blood. 2012 Aug 23;120(8):1562-9. doi: 10.1182/blood-2012-03-378901. Epub 2012 Jun 15.
Venous thromboembolism is a significant cause of illness and death worldwide. Large bodies of evidence support the heightened risk status of hospitalized medical patients, and that prophylactic measures significantly reduce the risk of thrombosis, yet these patients often fail to receive adequate prophylactic therapy. This failure may be accounted for by a lack of awareness of the relevant indications, poorly designed implementation systems, and clinical concerns over the side effects of anticoagulant medications. This article briefly summarizes our understanding of the clinical factors relevant to the evaluation of venous thromboembolism risk in hospitalized medical patients. We describe our approach to the use of thromboprophylaxis, through which we aim to minimize the disease burden of this under-recognized and preventable pathology.
静脉血栓栓塞症是全球范围内导致疾病和死亡的一个重要原因。大量证据表明,住院的内科患者具有更高的风险状态,预防措施可显著降低血栓形成的风险,但这些患者往往未能接受足够的预防治疗。这种失败可能是由于对相关适应证认识不足、实施系统设计不佳以及对抗凝药物副作用的临床担忧所致。本文简要总结了我们对内科住院患者静脉血栓栓塞症风险评估相关临床因素的理解。我们描述了使用血栓预防措施的方法,旨在通过这种方法将这种认识不足且可预防的疾病的负担降到最低。